SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
APPY Analysis & Videos »
APPY: Bull or Bear?
Regulatory Catalyst Extreme Trades: $APPA, $APPY $ARIA, $CTIC, $SOMX
APPY
|
|
|
-75.66%
in
811 days
<> The actively managed HavRx Regulatory Catalyst Index tracks the performance of select companies which meet any of the following requirements: (1) pending new drug, biological agent, medical device, or diagnostic product applications at the FDA; (2) pending pivotal clinical trial results that are designed to support a new filing or resubmission for FDA marketing clearance; and (3) pending early stage clinical study results. Categories (1) and (2) will comprise two-third (67%) or greater of all index components while companies with pending early stage clinical trial results will comprise one...
|
Extreme FDA Medical Device Trades: 7 Stocks Under $5
APPY
|
|
|
-4.64%
in
254 days
(closed on 03/16/10)
<> Below are extreme trades among companies with stock prices under $5 from the <font> BioMedReports.com FDA Calendar </font> , which includes 238 entries as of 7/5/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissio...
|
Updated Clinical Trial and FDA Decision Calendars
APPY
|
|
|
+29.51%
in
112 days
(closed on 07/05/09)
<> <> Below is a summary of updates to the www.BioMedReports.com database of 242 entries included in the FDA and Clinical Trial Calendars. The two web links below are for the FDA calendar home page and a recent article highlighting 14 extreme trades of companies with market caps below $200M with pending FDA decisions.
http://biomedreports <wbr> </wbr> .com/fda-calendar.ht <wbr> </wbr> ml
http://biomedreports <wbr> </wbr> .com/articles/most-p <wbr> </wbr> opular/627-trading-f <wbr> </wbr> da-decisions-14-extr <wbr> </wbr> eme-trades.html
The FDA Calenda...
|
20 Emerging Healthcare Stocks to Watch in '09
APPY
|
|
|
-77.17%
in
10 days
(closed on 01/20/09)
<> As a follow-up to my most recent article on the buyout binge among bio-pharma and diagnostic companies, below is a basket of 20 stocks (listed randomly) to consider from the ETF Innovators Indexes of 250 companies which represent a mix of pending catalysts in the form of clinical trials or FDA decisions, innovative patent portfolios or drug discovery technology platforms, promising compounds in clinical development, and marketed therapeutic or diagnostic products. Click on any of the company names for links to all of my prev...
|
Buyout Binge Begins for Bio-Pharma, Diagnostics
APPY
|
|
|
+0.00%
in
8 hours
(closed on 01/10/09)
<> 
<>
<> With news late Friday that Roche (RHHBY) is prepared to up its bid for complete control of Genentech (DNA) to $95 from a previous offer of $89 per share and a $41M ($1.50 per share) all-stock takeover offer by Sequenom (SQNM) for EXACT Sciences (EXAS); 2009 is off to a strong start for M&A activity in the bio-pharma and diagnostic space.
Larger and well funded bio-pharma and diagnostic companies are opportunistically looking to expand their product offerings, pipeline prospects, patent portfolios, ...
|
Virtual Investing at UpDown and MarketGuru
APPY
|
|
|
+0.75%
in
8 days
(closed on 01/10/09)
<>  <> The accompanying table includes the stocks in my MarketGuru virtual portfolio under MikeHavRx , which I began about one week ago.
Below is my current UpDown virtual investing portfolio, which is positioned to add some more offensive stock picks such as CME and Apple since it looks like the market rally is gaining momentum. Click on any of the company names below for a link to all of my articles.
Start earning real money with zero risk while improving your trading skills and strategies at the <> UpDow...
|
My UpDown Virtual Investing Portfolio
APPY
|
|
|
+3.60%
in
24 hours
(closed on 01/02/09)
<> 
Start earning real money with zero risk while improving your trading skills and strategies at the UpDown Virtual Investing website -- just click on the image above or any of the text links to the site in this article to sign up today. My stats and profile are featured in the accompanying table and on my blog site below the last posted entry. I started trading at the UpDown on 11/23/08 with a gain of 32.5% through today -- my profile name on the site is 'ETFinnovators' with a portfolio of long positions and link...
|
Four Healthy Stocks Trading Above Moving Averages
APPY
|
|
|
+1.98%
in
1 hour
(closed on 01/01/09)
Amgen (AMGN), AspenBio Pharma (APPY), BioDelivery Sciences (BDSI), and Cypress Bioscience (CYPB) are four healthcare stocks that I follow which are poised to close out a rough 2008 for the overall market trading above their 50 and 200-day moving averages, in addition to having significant catalysts in 2009 which may lead to further gains. Below is a summary of the 2009 catalysts for these companies and click on the names or tickers below for a link to all of the articles on my blog for each stock: <> Amgen filed a BLA for bone drug denosumab in the following two indicatio...
|
Anticipating Active '09 for AspenBio Pharma
APPY
|
|
|
-0.82%
in
14 hours
(closed on 12/31/08)
<> 
Now that AspenBio Pharma (APPY) has completed enrollment earlier this month in its FDA 510(k) clinical study for the world's first blood-based appendicitis screening test, AppyScore, investors will not have to wait much longer to get the results. Results in the 800 patient trial are expected in January, which will support APPY's 510(k) application for marketing clearance if the study objectives are met as in the previous, smaller clinical trial of AppyScore in 2007 with 98% sensitivity.
APPY expects to file it...
|
Top Five Rated Preventive Medicine Stocks
APPY
|
|
|
+5.35%
in
2 days
(closed on 12/31/08)
The table at my website link below presents statistics and the top five rated companies in the ETF Innovators [ETFI] Preventive Medicine Index. The index includes U.S.-listed companies with market caps of $150M-$45B which are engaged in healthcare business segments including diabetes care companies such as Novo Nordisk (NVO), vaccine makers such as Nabi Biopharma (NABI), diagnostics companies such as China Medical (CMED), and lab services companies such as LabCorp (LH). http://www.etfinnovators.com/2008/12/five-top-rated-preventiv... <> <> The Top 40 Rated companies have ou...
|
A New Emerging Diagnostics Index
APPY
|
|
|
-6.31%
in
3 days
(closed on 12/29/08)
<> 
The accompanying table [click to enlarge] includes 39 companies in the ETF Innovators [ETFI] Emerging Diagnostics Index of U.S.-listed stocks with market caps of $10-$200M. The index includes diabetes care device makers such as DexCom (DXCM), personalized medicine lab service providers such as Clarient (CLRT), clinical diagnostic test developers such as OraSure (OSUR), diagnostic imaging service providers such as Virtual Radiologic (VRAD), diagnostic equipment makers such as Vision Sciences (VSCI), and genetic analysis + molecu...
|
Five Healthcare Stocks for a Happy New Year
APPY
|
|
|
+11.96%
in
3 days
(closed on 12/26/08)
<> 
<>
The accompanying table includes a basket of five small-cap stocks chosen from the ETF Innovators [ETFI] new healthcare indexes. The five companies are trading above their 50-day moving averages with expected upside catalyst(s) in the next six months or less.
AMAG Pharma (AMAG) announced last evening that the FDA issued another complete response for its iron deficiency anemia drug ferumoxytol (Feraheme). More details are expected today at 8:30 AM [ET] when AMAG will hold a conference call , but the Company...
|
Stock Picks for a 'Roadhouse Blues' Market
APPY
|
|
|
+10.40%
in
32 days
(closed on 12/23/08)
<> The fear and pessimism behind major selling pressure and stock market losses can be summarized by the late Jim Morrison in a song by The Doors called 'Roadhouse Blues' – "The future's uncertain, and the end is always near." Some stocks that I follow which are trading at less than half of the 20% decline for the S&P 500 ETF (SPY) below its 50-day moving average are highlighted below.
Earlier this week, AspenBio Pharma (APPY) reported that its key clinical trial was nearly 90% enrolled for AppyScore, which is a blood-...
|
Six Healthcare Stocks on Sale
APPY
|
|
|
+2.04%
in
28 days
(closed on 11/21/08)
<> <> Despite the notion of investing in the healthcare sector as a safe haven, the following six companies (APPY, CMED, CYPB, DSCO, MYL, PFE) are all down sharply over the past year despite solid underlying fundamentals, which are largely unaffected by global economic conditions.
Diagnostics
China Medical (CMED) is trading near its IPO levels of August 2005 despite excellent growth prospects and a PEG ratio of 0.3X, a forward PE of 8X, and a dividend yield of 1.8%. For some perspective on the velocity of the downturn in CMED, the s...
|
Market Notes: AspenBio Pharma + Microsoft-Yahoo!?
APPY
|
|
|
+8.89%
in
8 days
(closed on 10/24/08)
<> 
<> AspenBio Pharma (APPY) should be close to completing patient enrollment in its 510(k) clinical trial for AppyScore based on its previous update in early September when the trial had reached the half-way point in terms of enrolling patients. AppyScore is the world's first blood-based diagnostic tool for human appendicitis and APPY expects to file the 510(k0 before year-end with potential approval in early 2009.
Steve Ballmer states that a Microsoft buyout of Yahoo! would still make sense economically, but t...
|
People Bullish on APPY
People Bearish on APPY
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on APPY |
Be the first to start a discussion and earn 2 points.
More Resources
|
About AspenBio Pharma Inc.
- Answers.com
